Combined use of both compounds is entirely unstudied in humans and carries unpredictable metabolic and cardiovascular risks
As of 2026, 5-Amino-1MQ is not approved by any regulatory authority (FDA, EMA, ANSM)
Women who are pregnant, breastfeeding, or planning pregnancy should not use research peptides
GHK-Cu operates through at least six distinct biological pathways simultaneously which is what distinguishes it from most single-pathway peptides in the research literature
The Protocol Components of LIPO-C with added B12: Lipo-C Compound : A specialized lipotropic combination researched for its role in cellular fat oxidation, lipid export optimization, and methyl donor signaling pathways
In 2010, results from a phase II study of single-agent pazopanib in patients with recurrent or metastatic breast cancer revealed promising activity in terms of disease stability and tolerable adverse events (Taylor et al., 2010)